Alexander Kenigsberg, MD, (Alexander Kenigsberg) discusses a new option for treating prostate cancer: robotic high-intensity focused ultrasound. #pcsm | VCU Urology VCU Massey Comprehensive Cancer Center hubs.li/Q03pK5bD0

"This HIFU technology is associated with the lowest risk of side effects. Specifically, the risk of erectile disfunction is lower than seen with surgery or radiation. The risk of incontinence using zero pads is lower than seen with surgery and radiation." Michael Ahdoot MD

This week was the Jefferies Global Healthcare Conference in New York City! Focal One's CEO, Ryan Rhodes, presented on Thursday, June 5 at 4:20 p.m. EDT. If you didn't get a chance to tune in live, visit our website to watch to the recording: investor.focalone.com/events/event-d… #Cancer |

It’s Men’s Health Week! At Focal One, we’re committed to driving awareness of prostate cancer, the most common cancer in men worldwide. We encourage all men to prioritize their health by getting their PSA checked to screen for prostate cancer. To learn more about Focal One, the

Congratulations to Cleveland Clinic London and Prof. Senthil Nathan on this remarkable achievement and the successful launch of their Focal Therapy program! We are proud to see our global network of physicians and hospitals growing rapidly, bringing Focal One as a non-invasive option

Leading Urologic Oncologist from NYU Langone, James Wysock, MD was recently interviewed on Fans for the Cure's Stay in the Game podcast. Dr. Wysock discusses the evolution of focal therapy and Focal One as an option in the management of Prostate Cancer: "It's non-invasive.

Did you know that prostate cancer is the number one cancer among men in the United States? In honor of the men's health initiatives that are being celebrated throughout June, we want to continue emphasizing the importance of knowing what your treatment options are if you've been

On this #MilestoneMonday, we want to congratulate David A. Taub, MD and the staff at Baptist Health Cancer Care Boca Raton Regional Hospital for treating their 50th patient with Focal One! To learn more about Focal One, the non-invasive, nonsurgical option for prostate treatment, visit

#AUA25 was packed with exciting moments including the debut of the Focal One i, our most advanced innovation yet! Watch the video below to hear from Hugo Embert, VP of Marketing and Reimbursement at Focal One, as he dives into what makes this evolution so groundbreaking. Thank

As Men's Health Month comes to a close, we would like to shed light on the importance of getting your PSA checked. With the recent news of Former President Joe Biden's prostate cancer diagnosis, getting screened could be key in detecting cancer early. To learn more about

Focal One is the leading non-invasive, non-surgical option for the ablation of prostate tissue in the management of prostate cancer. Our technology only targets the diseased parts of the prostate without damaging healthy surrounding tissue and critical structures. The

Unlike traditional approaches to prostate cancer, Focal One targets only the diseased part of the prostate using high-performance imaging and precise focused ultrasound technology. The goal? Destroy the tumor. Preserve urinary and sexual function. Maintain patients' quality

Don't miss key Focal One Robotic HIFU and Focal Therapy talks by Pr. Sébastien Crouzet with experience performing over 3,000 HIFU procedures and Focal Therapy expert [email protected] at the #SRS2025 Annual Meeting in Strasbourg on July 17. You can also stop by the Focal One

Focal One allows urologists to target only the diseased portion of the prostate, minimizing the risk of damage to surrounding healthy tissue leading to less side effects. There is no blood loss, no scar, and no radiation involved in this procedure. To read more about how

Vernon had an elevated PSA and was diagnosed with intermediate risk prostate cancer. After consulting with his Urologist Gopal Gupta, MD from Loyola Medicine, Vernon was treated with Focal One, a non-invasive, nonsurgical option in the management of prostate cancer. "After three

Sudhir Isharwal, MD, Urologic Oncologist at OHSU Knight Cancer Institute, explains how Focal One offers a non-invasive alternative to traditional prostate cancer treatments like surgery. "There are no cuts. There are no incisions to heal from. So patients feel that they did not have any